Cipla Limited has notified that the United States Food and Drug Administration (USFDA) conducted a 'current Good Manufacturing Practices' (cGMP) inspection at its Pithampur manufacturing facility from 6th – 17th February, 2023, via an exchange filing.
The company received 8 inspectional observations in Form 483 at the end of the inspection. The company will work closely with the USFDA and is committed to address these comprehensively within the stipulated time.
The disclosure is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Vivek Agnihotri Says He Borrowed Money For Flight Tickets To Promote The Bengal Files, Admits Financial Struggles: 'Nobody Backs Our Films'
Heartbreaking! Alex Marquez's Team Box Left In Disbelief As He Crashes During MotoGP Sprint Race At Catalan Grand Prix; Video
Mumbai: Devendra Fadnavis & Eknath Shinde Shower Flowers On Bappa At Girgaon Chowpatty
UP T20 League: CM Yogi Adityanath Spins The Coin During Toss Ahead Of Final; Video
